1. United States of America Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
Deltagen Inc.

Deltagen Inc.

DGEN
Deltagen Inc.US flagOther OTC
0.00
USD
- -
- -
3,859.00Market Cap
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
2005 Y
2006 Y
TTM
Revenue per Share
- -
1.15
0.16
0.34
0.47
0.17
0.25
0.13
Basic EPS, GAAP
- -
-12.82
-4.32
-1.64
-2.83
- -
0.11
0.05
Free Cash Flow per Basic Share
- -
-9.92
-1.38
-1.66
-2.24
- -
0.05
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
0.2
- -
Book Value per Share
- -
-17.09
-4.01
-3.36
-5.45
-5.84
-5.66
-5.68
Tangible Book Value per Share
- -
-14.23
8.78
2.66
0.67
0.25
0.23
0.16
Basic Weighted Avg Shares
- -
1
13
29
38
39
39
39
Sales/Revenue/Turnover
- -
1
2
10
18
7
10
5
Operating Margin (%)
- -
-1,115.81
-1,694.71
-526.35
-401.68
-6.88
40.44
11.18
Depreciation Expense
- -
1
1
3
10
- -
- -
- -
Net Income, GAAP
- -
-14
-32
-48
-107
- -
4
2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-1,116.69
-1,549.09
-488.97
-605.81
-2.27
44.66
38.08
Working Capital
- -
-4
108
62
-10
10
8
5
LT Debt
- -
2
3
3
3
- -
- -
- -
Total Equity
- -
-15
111
84
31
10
9
6
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
7.76
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'06
Mar'07
Jun'07
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
39
39
- -
Market Capitalization
18
15
13

Working Capital

FRC

•

in mil. unless spec.
Dec'06
Mar'07
Jun'07
Total Current Assets
9
8
6
Cash, Cash Equivalents & STI
6
5
3
Accounts Receivable, Net
2
1
2
Inventories
- -
- -
- -
Total Current Liabilities
1
- -
- -
Payables & Accruals
1
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-197.34%
-9.01%
Free Cash Flow
- -
- -
-102.36%
Net Income, GAAP
- -
-553.86%
-2,973.68%
Sales/Revenue/Turnover
- -
101.3%
45.95%
Total Cash Common Dividend
- -
- -
-134.52%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
5
- -
- -
- -
7
2006
2
4
1
3
10
2007
- -
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
-0.45
- -
- -
- -
- -
2006
0.01
- -
- -
- -
0.11
2007
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
- -
- -
- -
- -
- -
2006
- -
- -
- -
- -
0.2
2007
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Robert J. Driscoll
Sector
Industrials
Industry
Specialty Business Services
Address
1900 South Norfolk Street San Mateo CA United States of America 94403
IPO Date
Aug 3, 2000
Website
d-gen.co.il
Similar Companies
Voyager Digital Ltd. (VYGVQ)
Almunda Professionals N.V. (AMUND.AS)
Farglory F T Z Investment Holding Co.,Ltd. (5607.TW)
Mon Courtier Energie Groupe S.A. (ALMCE.PA)
HCS Holdings Co.,Ltd. (4200.T)
Aramark (ARMK)
Business
Deltagen Inc. (DGEN) provides drug discovery tools and services to the biopharmaceutical industry; it offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, small-molecule and secreted protein drug targets, and target validation data in the areas of immunology and metabolic diseases. The company develops technology that converts raw data into mammalian gene function information to help pharmaceutical and biotechnology companies expedite the drug discovery process through advanced bioinformatics and novel gene target identification. Incorporated in 1999 and headquartered at 1900 South Norfolk Street, Suite 105, San Mateo, California, USA, Deltagen operates primarily in the life sciences tools and services segment of the pharmaceuticals and biotechnology sector, targeting biopharmaceutical firms with its specialized offerings.